Evidence map›Paper›PMID 40633838›Full record

ArticleJournal of advanced research2026

Endothelial cells secrete small extracellular vesicles to promote neuron endoplasmic reticulum stress injury via miR-146a-5p/Eif4g2 axis in ischemic stroke.

Meiqi Jin, Yueqiusha Wang, Shuxia Zhang, Yunqi Zhang, Tao Liu, Yun Luo, Xiaobo Sun

Abstract read
In one paragraph

Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meiqi JinInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100193, China; Beijing Key Laboratory of Neuroinnovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China; Central Laboratory, Harbin 242 Hospital, Harbin, China.
Yueqiusha WangInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100193, China; Beijing Key Laboratory of Neuroinnovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China.
Shuxia ZhangInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100193, China; Beijing Key Laboratory of Neuroinnovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China.
Yunqi ZhangInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100193, China; Beijing Key Laboratory of Neuroinnovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China.
Tao LiuCentral Laboratory, Harbin 242 Hospital, Harbin, China.
Yun LuoInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100193, China; Beijing Key Laboratory of Neuroinnovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China. Electronic address: ly20040423@126.com.
Xiaobo SunInstitute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100193, China; Beijing Key Laboratory of Neuroinnovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China. Electronic address: sun_xiaobo163@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIschemic stroke (IS) ranks among the top global causes of mortality and disability, with existing treatments proving inadequate because of its complex pathological process. Cell communication mediated by extracellular vesicle (EV)-containing miRNAs between vascular endothelial cells and neurons is essential for IS formation.

objectivesThis research sought to explore the effects and molecular mechanisms of endothelial cell EV-derived miR-146a-5p on neuron injury in IS.

methodsWe investigated the role of miR-146a-5p in IS using a middle cerebral artery occlusion/reperfusion (MCAO/R) rat model and oxygen-glucose deprivation/reperfusion (OGD/R) endothelial cells. We characterized miR-146a-5p expression in small EVs (sEVs) derived from MCAO/R rat brains and OGD/R endothelial cells, and the miR-146a-5p target to Eif4g2 expression. Neuronal injury was assessed by apoptosis induction and proliferation inhibition.

resultsThe expression level of miR-146a-5p in sEVs was significantly elevated in the brains of MCAO/R rats and in OGD/R endothelial cells, correlating with increased neuron injury via apoptosis induction and proliferation inhibition. Transfer of miR-146a-5p to neurons through sEVs targeted and inhibited Eif4g2, triggering endoplasmic reticulum stress-mediated neuron injury. Increasing and decreasing miR-146a-5p expression levels significantly promoted and ameliorated neuron injury, respectively. Additionally, we identified the neuroprotective agent of 3-n-butyl phthalide (NBP) as a potential miR-146a-5p targeted inhibitor using molecular docking analysis and validated.

conclusionOur research clarifies the role of miR-146a-5p-containing sEVs in inducing neuron injury by targeting Eif4g2-mediated ER stress in IS. Additionally, we demonstrated a new mechanism for NBP treating IS. These results clarify the molecular mechanisms of IS pathogenesis and provide perspectives on new therapeutic approaches.

Indexed as

Endoplasmic Reticulum StressEndothelial CellsEukaryotic Initiation Factor-4GExtracellular VesiclesIschemic StrokeMicroRNAsNeuronsAnimalsApoptosisDisease Models, AnimalInfarction, Middle Cerebral ArteryMaleRatsRats, Sprague-DawleyReperfusion InjuryEukaryotic Initiation Factor-4GMicroRNAsMIRN146 microRNA, ratEndothelial cellsER stressIschemic strokemiR-146a-5pNeuron injurySmall extracellular vesicles

Identifiers

PMID40633838
PMCPMC13001036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.